DENTSPLY SIRONA Stock Forecast, Price & News

13 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" DENTSPLY SIRONA stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in XRAY, but not buy additional shares or sell existing shares.
View analyst ratings for DENTSPLY SIRONA or view top-rated stocks.

Wall Street analysts have given DENTSPLY SIRONA a "Hold" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but DENTSPLY SIRONA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

DENTSPLY SIRONA saw a decrease in short interest in March. As of March 31st, there was short interest totaling 2,500,000 shares, a decrease of 21.1% from the March 15th total of 3,170,000 shares. Based on an average trading volume of 1,600,000 shares, the short-interest ratio is presently 1.6 days. Approximately 1.2% of the shares of the company are short sold.
View DENTSPLY SIRONA's Short Interest.

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for DENTSPLY SIRONA.

DENTSPLY SIRONA will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) released its quarterly earnings data on Sunday, February, 28th. The medical instruments supplier reported $0.87 earnings per share for the quarter, topping analysts' consensus estimates of $0.64 by $0.23. The medical instruments supplier had revenue of $1.08 billion for the quarter, compared to analysts' expectations of $997.38 million. DENTSPLY SIRONA had a positive trailing twelve-month return on equity of 7.13% and a negative net margin of 1.40%. DENTSPLY SIRONA's revenue was down 2.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.73 earnings per share.
View DENTSPLY SIRONA's earnings history.

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XRAY shares have increased by 54.0% and is now trading at $65.53.
View which stocks have been most impacted by COVID-19.

DENTSPLY SIRONA announced a quarterly dividend on Wednesday, February 24th. Investors of record on Friday, March 26th will be given a dividend of $0.10 per share on Friday, April 9th. This represents a $0.40 annualized dividend and a dividend yield of 0.61%. The ex-dividend date is Thursday, March 25th.
View DENTSPLY SIRONA's dividend history.

DENTSPLY SIRONA pays an annual dividend of $0.40 per share and currently has a dividend yield of 0.61%. DENTSPLY SIRONA does not yet have a strock track record of dividend growth. The dividend payout ratio of DENTSPLY SIRONA is 16.33%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 18.10% next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.
View DENTSPLY SIRONA's dividend history.

DENTSPLY SIRONA updated its FY21 earnings guidance on Monday, March, 1st. The company provided EPS guidance of $2.60-2.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.40.

13 brokerages have issued 12 month price objectives for DENTSPLY SIRONA's shares. Their forecasts range from $38.00 to $71.00. On average, they anticipate DENTSPLY SIRONA's stock price to reach $55.33 in the next twelve months. This suggests that the stock has a possible downside of 15.6%.
View analysts' price targets for DENTSPLY SIRONA or view top-rated stocks among Wall Street analysts.

105 employees have rated DENTSPLY SIRONA CEO Don Casey on Glassdoor.com. Don Casey has an approval rating of 70% among DENTSPLY SIRONA's employees.

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), West Pharmaceutical Services (WST), The Cooper Companies (COO), Haemonetics (HAE), STAAR Surgical (STAA), Quidel (QDEL), Neogen (NEOG), ICU Medical (ICUI), Merit Medical Systems (MMSI), Atrion (ATRI), Meridian Bioscience (VIVO), Cerus (CERS), OraSure Technologies (OSUR), Antares Pharma (ATRS) and Anika Therapeutics (ANIK).
View all of XRAY's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), The Boeing (BA), General Electric (GE), International Business Machines (IBM), Broadcom (AVGO), Comcast (CMCSA), Gilead Sciences (GILD) and Tesla (TSLA).

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

DENTSPLY SIRONA's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.23%), Kirr Marbach & Co. LLC IN (0.06%), State of Alaska Department of Revenue (0.06%), Royal London Asset Management Ltd. (0.04%), Retirement Systems of Alabama (0.04%) and Cardinal Capital Management (0.04%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman, William E Newell and Willie A Deese.
View institutional ownership trends for DENTSPLY SIRONA.

XRAY stock was sold by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue, Wedge Capital Management L L P NC, Dalton Greiner Hartman Maher & Co., Retirement Systems of Alabama, Kirr Marbach & Co. LLC IN, Crossmark Global Holdings Inc., Pacer Advisors Inc., and Domani Wealth LLC. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Eric Brandt, Michael C Alfano, William E Newell, and Willie A Deese.
View insider buying and selling activity for DENTSPLY SIRONA or view top insider-selling stocks.

XRAY stock was purchased by a variety of institutional investors in the last quarter, including Everence Capital Management Inc., Courier Capital LLC, DnB Asset Management AS, Royal London Asset Management Ltd., Sound Income Strategies LLC, Livingston Group Asset Management CO operating as Southport Capital Management, Cardinal Capital Management, and CX Institutional. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier.
View insider buying and selling activity for DENTSPLY SIRONA or or view top insider-buying stocks.

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XRAY stock can currently be purchased for approximately $65.53.

DENTSPLY SIRONA has a market capitalization of $14.35 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis.

DENTSPLY SIRONA employs 15,000 workers across the globe.

DENTSPLY SIRONA was founded in 2016.

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

DENTSPLY SIRONA is headquartered at 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277.

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]